Edition:
United States

People: Dr.Reddy's Laboratories Ltd (RDY.N)

RDY.N on New York Stock Exchange

44.77USD
23 May 2016
Change (% chg)

$-0.01 (-0.02%)
Prev Close
$44.78
Open
$44.83
Day's High
$45.13
Day's Low
$44.65
Volume
58,965
Avg. Vol
91,617
52-wk High
$68.00
52-wk Low
$40.74

Prasad, G. 

Mr. G. V. Prasad is Co-Chairman of the Board, Chief Executive Officer, Managing Director of Dr. Reddy’s Laboratories Limited since May 2014. Mr. G V Prasad joined the Company’s Board in 1986 and leads the core team that drives the growth and performance of Dr. Reddy’s. Following the demise of Dr. K Anji Reddy, he has been appointed as Chairman and CEO effective 30 March 2013. He became Vice-Chairman & CEO of Dr. Reddy’s in 2001, when Cheminor Drugs Limited, the company of which he was then Managing Director, merged with Dr. Reddy’s. Prasad has played a key role in the evolution of Dr. Reddy’s from a mid-sized pharmaceutical company into a globally respected pharmaceutical. He is widely credited as the architect of Dr. Reddy’s global generics strategy. He is dedicated to building the innovation side of the business and drives the Sustainability agenda at Dr. Reddy’s. He nurtured new lines of business, helped to build a high-talent organization, and was instrumental in introducing best-in-class practices in corporate governance. Prasad holds a degree in Chemical Engineering from the Illinois Institute of Technology, Chicago, USA and a Masters in Industrial Administration from Purdue University, USA.

Basic Compensation

Total Annual Compensation, INR 106,300,000
Restricted Stock Awards, INR --
Long-Term Incentive Plans, INR --
All Other, INR 3,164,000
Fiscal Year Total, INR 109,464,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Satish Reddy

114,639

G. Prasad

109,464,000

Saumen Chakraborty

15,000,000

Sripada Chandrasekhar

--

Abhijit Mukherjee

14,600,000

Amit Biswas

--
As Of  30 Mar 2014